Barclays
LTHM

Barclays’s Livent Corporation LTHM Stock Holding History

Barclays’s Portfolio LTHM Stock Details LTHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,209
Closed -$8K – 7249
2019
Q2 		$8K Sell
1,209
-930
-43% -$8.35K ﹤0.01% 6621
2019
Q1 		$26K Buy
+2,139
New +$27.9K ﹤0.01% 6250

Other funds holding LTHM

MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
MLICM
Metropolitan Life Insurance Company (MetLife) New York $328M AUM 9.77% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
ACA
American Capital Advisory Ketchum, Idaho $248M AUM 21.64% 1-Year Est. Return

Barclays's LTHM Position: Q1 2024 in Review

Barclays sold out of Livent Corporation (LTHM) in Q1 2024, closing a stake of 1,868,768 shares — an estimated $33.6M sold.

Barclays first reported a position in LTHM in Q4 2018 and held it in 21 quarters. The position peaked at $33.6M in Q4 2023. 6 funds tracked by Wall St. Rank hold LTHM as of Q1 2024.

  • Barclays reported no remaining Livent Corporation position as of Q1 2024 after selling out during the quarter.
  • Barclays sold 1,868,768 Livent Corporation shares in Q1 2024, an estimated $33.6M.
  • Barclays first reported a position in Livent Corporation in Q4 2018 and held it in 21 quarters.
  • Barclays's Livent Corporation position peaked at $33.6M in Q4 2023.
  • 6 funds tracked by Wall St. Rank held Livent Corporation as of Q1 2024.

Based on Barclays's 13F filing for Q1 2024, filed 15 May 2024.